193 related articles for article (PubMed ID: 30254456)
21. Downregulation of long non-coding RNA ENSG00000241684 is associated with poor prognosis in advanced clear cell renal cell carcinoma.
Su H; Wang H; Shi G; Zhang H; Sun F; Ye D
Eur J Surg Oncol; 2018 Jun; 44(6):840-846. PubMed ID: 29433989
[TBL] [Abstract][Full Text] [Related]
22. LINC01480 as a Prognostic Biomarker Associated With Proliferation, Migration, and Invasion of Clear Cell Renal Cell Carcinoma.
Ma Y; Wu C; Deng S
Anticancer Res; 2023 Jul; 43(7):3037-3046. PubMed ID: 37351956
[TBL] [Abstract][Full Text] [Related]
23. Long Non-Coding RNA LUCAT1 Promotes Proliferation and Invasion in Clear Cell Renal Cell Carcinoma Through AKT/GSK-3β Signaling Pathway.
Zheng Z; Zhao F; Zhu D; Han J; Chen H; Cai Y; Chen Z; Xie W
Cell Physiol Biochem; 2018; 48(3):891-904. PubMed ID: 30032137
[TBL] [Abstract][Full Text] [Related]
24. Upregulation of lncRNA AGAP2-AS1 is an independent predictor of poor survival in patients with clear cell renal carcinoma.
Gao L; Zhao A; Wang X
Oncol Lett; 2020 Jun; 19(6):3993-4001. PubMed ID: 32382344
[TBL] [Abstract][Full Text] [Related]
25. Long Non-Coding RNA TTN-AS1 Serves as a Competing Endogenous RNA of miR-195 to Facilitate Clear Cell Renal Cell Carcinoma Progression.
Lin K; Chen H; Su C; Zhu H; Lai C; Shi Y
Cancer Manag Res; 2020; 12():3091-3097. PubMed ID: 32440207
[TBL] [Abstract][Full Text] [Related]
26. LncRNA NR2F2-AS1 Upregulates Rac1 to Increase Cancer Stemness in Clear Cell Renal Cell Carcinoma.
Chen L; Zhang D; Ding T; Liu F; Xu X; Tian Y; Xiao J; Shen H
Cancer Biother Radiopharm; 2020 May; 35(4):301-306. PubMed ID: 32109138
[No Abstract] [Full Text] [Related]
27. Microtubule-associated protein tau (MAPT) is a promising independent prognostic marker and tumor suppressive protein in clear cell renal cell carcinoma.
Han X; Sekino Y; Babasaki T; Goto K; Inoue S; Hayashi T; Teishima J; Sakamoto N; Sentani K; Oue N; Yasui W; Matsubara A
Urol Oncol; 2020 Jun; 38(6):605.e9-605.e17. PubMed ID: 32139291
[TBL] [Abstract][Full Text] [Related]
28. Lymph node metastasis-related lncRNA GAS6-AS1 facilitates the progression of esophageal squamous cell carcinoma.
Xie Y; Zhang Z; Lai D; Liang J; Zhao Z; Lu W; Ke J; Lin W; He H
J Gastrointest Oncol; 2023 Dec; 14(6):2293-2308. PubMed ID: 38196547
[TBL] [Abstract][Full Text] [Related]
29. An increase in long non-coding RNA PANDAR is associated with poor prognosis in clear cell renal cell carcinoma.
Xu Y; Tong Y; Zhu J; Lei Z; Wan L; Zhu X; Ye F; Xie L
BMC Cancer; 2017 May; 17(1):373. PubMed ID: 28545465
[TBL] [Abstract][Full Text] [Related]
30. Long Non-Coding RNA PCED1B-AS1 Promotes the Progression of Clear Cell Renal Cell Carcinoma Through miR-484/ZEB1 Axis.
Qin J; Zhu T; Wu W; Chen H; He Y
Onco Targets Ther; 2021; 14():393-402. PubMed ID: 33469315
[TBL] [Abstract][Full Text] [Related]
31. DARS-AS1 promotes clear cell renal cell carcinoma by sequestering miR-194-5p to up-regulate DARS.
Jiao M; Guo H; Chen Y; Li L; Zhang L
Biomed Pharmacother; 2020 Aug; 128():110323. PubMed ID: 32526457
[TBL] [Abstract][Full Text] [Related]
32. Long non-coding RNA ARAP1-AS1 contributes to cell proliferation and migration in clear cell renal cell carcinoma via the miR-361-3p/placental growth factor axis.
Zhong L; Zhong X
Bioengineered; 2021 Dec; 12(1):6629-6642. PubMed ID: 34516333
[TBL] [Abstract][Full Text] [Related]
33. Expression of long non-coding RNA MFI2-AS1 is a strong predictor of recurrence in sporadic localized clear-cell renal cell carcinoma.
Flippot R; Mouawad R; Spano JP; Rouprêt M; Compérat E; Bitker MO; Parra J; Vaessen C; Allanic F; Manach Q; Tannir NM; Khayat D; Su X; Malouf GG
Sci Rep; 2017 Aug; 7(1):8540. PubMed ID: 28819235
[TBL] [Abstract][Full Text] [Related]
34. LncRNA LBX2-AS1 promotes proliferation and migratory capacity of clear cell renal cell carcinoma through mitophagy.
Wang B; Wei Y; Han T; Ji P; Miao H; Wu X; Qian J; Shao P
Eur J Med Res; 2024 Feb; 29(1):103. PubMed ID: 38326905
[TBL] [Abstract][Full Text] [Related]
35. Long noncoding RNA ZFPM2-AS1 promotes the tumorigenesis of renal cell cancer via targeting miR-137.
Liu JG; Wang HB; Wan G; Yang MZ; Jiang XJ; Yang JY
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5675-5681. PubMed ID: 31298319
[TBL] [Abstract][Full Text] [Related]
36. Restoring the epigenetically silenced lncRNA COL18A1-AS1 represses ccRCC progression by lipid browning via miR-1286/KLF12 axis.
Liu Y; Wang J; Shou Y; Xu W; Huang Z; Xu J; Chen K; Liu J; Liu D; Liang H; Yang H; Zhang X
Cell Death Dis; 2022 Jul; 13(7):578. PubMed ID: 35787628
[TBL] [Abstract][Full Text] [Related]
37. A nomogram based on 9-lncRNAs signature for improving prognostic prediction of clear cell renal cell carcinoma.
Jiang W; Guo Q; Wang C; Zhu Y
Cancer Cell Int; 2019; 19():208. PubMed ID: 31404170
[TBL] [Abstract][Full Text] [Related]
38. Pro-Angiogenic and Pro-Inflammatory Regulation by lncRNA MCM3AP-AS1-Mediated Upregulation of DPP4 in Clear Cell Renal Cell Carcinoma.
Qiu L; Ma Y; Yang Y; Ren X; Wang D; Jia X
Front Oncol; 2020; 10():705. PubMed ID: 32714856
[TBL] [Abstract][Full Text] [Related]
39. LncRNA, NEAT1 is a prognosis biomarker and regulates cancer progression via epithelial-mesenchymal transition in clear cell renal cell carcinoma.
Ning L; Li Z; Wei D; Chen H; Yang C
Cancer Biomark; 2017; 19(1):75-83. PubMed ID: 28269753
[TBL] [Abstract][Full Text] [Related]
40. Upregulation of CCNB2 and a novel lncRNAs-related risk model predict prognosis in clear cell renal cell carcinoma.
Ren C; Wang Q; Xu Z; Pan Y; Wang S; Liu X
J Cancer Res Clin Oncol; 2024 Feb; 150(2):64. PubMed ID: 38300330
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]